{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:23:54Z","timestamp":1771334634068,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2007,4,1]]},"DOI":"10.2174\/138161207780618849","type":"journal-article","created":{"date-parts":[[2007,5,2]],"date-time":"2007-05-02T11:33:48Z","timestamp":1178105628000},"page":"1285-1294","source":"Crossref","is-referenced-by-count":20,"title":["The Protease of Human T-Cell Leukemia Virus Type-1 is a Potential Therapeutic Target"],"prefix":"10.2174","volume":"13","author":[{"given":"Jozsef","family":"Tozser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/59221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T09:15:43Z","timestamp":1448010943000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=13&issue=12&spage=1285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,4,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138161207780618849","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4,1]]}}}